» Articles » PMID: 32180597

The Current Indian Epidemic of Dermatophytosis: A Study on Causative Agents and Sensitivity Patterns

Overview
Specialty Dermatology
Date 2020 Mar 18
PMID 32180597
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the recent years, the frequency, severity, clinical characteristics, treatment response, and relapse rate of dermatophytosis have dramatically changed in India. Given the surge in dermatophytosis, we had undertaken a study to isolate and identify the common species causing dermatophyte infection and to know the efficacy of the common antifungals against them.

Materials And Methods: A total of 103 new cases that were not on any treatment for the past 3 months were included. Skin scrapings were collected for direct microscopic examination and for fungal culture in Sabouraud 4% dextrose agar (SDA) with chloramphenicol and cycloheximide slant tubes, and dermatophyte test media. Fungi were identified on the basis of their macroscopic and microscopic features with the help of lactophenol cotton blue staining and urease test. Also, the drug sensitivity of the dermatophytes was tested with the common antifungals.

Results: Of the 55 cases (53.4%) that were positive for dermatophytes in the culture, 29 showed possible contamination. was the predominant organism (49 cases) with being the commonest species (26 cases), followed by (15 patients), and (8 cases). All species of were found to be most sensitive to itraconazole amongst systemic antifungals and luliconazole amongst topical antifungals.

Conclusion: This study concluded that the causative agent for the dermatophytosis was changing in India and in our subset, caused the maximum number of infections. Itraconazole and luliconazole had the highest sensitivity amongst systemic and topical antifungals, respectively. It also showed that terbinafine had comparatively less sensitivity to most organisms.

Citing Articles

Clinical and Microbiological Spectrum of Dermatophytosis From a Tertiary Care Institute.

Sudhaharan S, Shaw D, Naaz S, Kovida S, Pamidimukkala U Cureus. 2025; 17(1):e77523.

PMID: 39958119 PMC: 11829238. DOI: 10.7759/cureus.77523.


A Road Less Traveled: E-test Method for Antifungal Susceptibility Testing in Trichophyton mentagrophyte Isolates Among Patients Presenting With Dermatophytosis at a Tertiary Healthcare Center in North India.

Maurya K, Raj N, Singh A, Das A, Sen M, Garg J Cureus. 2024; 16(6):e62047.

PMID: 38989328 PMC: 11234478. DOI: 10.7759/cureus.62047.


Hypothalamus-pituitary-adrenal axis (HPA axis) suppression with inappropriate use of steroids in recalcitrant dermatophytosis - A cross-sectional study.

Kaur T, Bassan M, Bisht M, Kumar N, Saini P, Hazarika N J Family Med Prim Care. 2024; 13(5):2026-2031.

PMID: 38948600 PMC: 11213414. DOI: 10.4103/jfmpc.jfmpc_1330_23.


Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial.

Shenoy M, De A, Shah B, Das A, Saraswat A, Lahiri K Drug Des Devel Ther. 2023; 17:2899-2908.

PMID: 37766823 PMC: 10520254. DOI: 10.2147/DDDT.S421583.


Management of Dermatophytosis: Real-World Indian Perspective.

Shenoy M, Poojari S, Rengasamy M, Vedmurthy M, Barua S, Dhoot D Indian Dermatol Online J. 2023; 14(3):347-356.

PMID: 37266073 PMC: 10231727. DOI: 10.4103/idoj.idoj_643_22.


References
1.
Noronha T, Tophakhane R, Nadiger S . Clinico-microbiological study of dermatophytosis in a tertiary-care hospital in North Karnataka. Indian Dermatol Online J. 2016; 7(4):264-71. PMC: 4976403. DOI: 10.4103/2229-5178.185488. View

2.
Ramaraj V, Vijayaraman R, Hemanth V, Rangarajan S, Kindo A . Molecular strain typing of ( var. ) using non-transcribed spacer region as a molecular marker. Indian J Med Res. 2018; 146(5):636-641. PMC: 5861475. DOI: 10.4103/ijmr.IJMR_51_15. View

3.
Singh S, Shukla P . End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients. Indian J Dermatol Venereol Leprol. 2018; 84(5):554-557. DOI: 10.4103/ijdvl.IJDVL_526_17. View

4.
Bishnoi A, Vinay K, Dogra S . Emergence of recalcitrant dermatophytosis in India. Lancet Infect Dis. 2018; 18(3):250-251. DOI: 10.1016/S1473-3099(18)30079-3. View

5.
Lakshmanan A, Ganeshkumar P, Mohan S, Hemamalini M, Madhavan R . Epidemiological and clinical pattern of dermatomycoses in rural India. Indian J Med Microbiol. 2015; 33 Suppl:134-6. DOI: 10.4103/0255-0857.150922. View